I am/have/had
I am looking for
Advanced Filters
Found 242 clinical trials
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.
positron emission tomography
ebv-positive dlbcl, nos
g-csf
b-cell lymphoma
tubal ligation
- 0 views
- 19 Feb, 2024
Lenalidomide in Combination With CHOP in Patients With Untreated PTCL
The prognosis of PTCL (except early stage ALK+ ALCL) is dismal. Previous study showed that single agent lenalidomide showed promising therapeutic activity in patients with relapsed or refractory PTCL.
peripheral t-cell lymphoma
anaplastic large cell lymphoma
lenalidomide
- 0 views
- 19 Feb, 2024